Our approach
Our approach to access is tailored and on a medicine- and country-specific basis, taking into account a range of factors including local disease burden, health and economic value of the medicine, and local economic conditions.
Our health economists study the impact of our medicines and patient support programs on health outcomes, use of other health services, and activities of daily living.
We work closely with payers and health technology assessment organizations to build shared understanding of how our medicines create value and impact overall health budgets.
